journal article·2022-03-14

Liposomal Targeting Modifies Endosomal Escape: Design and Mechanistic Implications

Franklin Mejia, Sabrina Khan, Basar Bilgicer

Publisher page

Abstract

Development of effective targeted nanoparticle (TNP) therapeutics requires rational design of targeted and endosomolytic moieties. Nevertheless, endosomal escape of TNPs is poorly understood, relying on extrapolation of knowledge from nontargeted (NP) systems. Here, we describe how incorporation of targeting elements on endosomolytic nanoparticles alters the endosomal escape mechanism. We demonstrated that NP and TNP systems react differently to addition of precise length oligohistidines and showcase the effects of alternating spatial arrangements of targeting and endosomolytic elements. The results established that these elements act cooperatively and must be incorporated as individual moieties, rather than a single multifunctional moiety, for optimal internalization by target cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States

Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana 46556, United States

Berthiaume Institute for Precision Health, University of Notre Dame, Notre Dame, Indiana 46556, United States

Funding

Walther Cancer Foundation

References (34)

Show source-provided references
1. 10.3389/fphar.2018.0079010.3389/fphar.2018.00790 ↗
2. 10.1038/s41467-018-03705-y10.1038/s41467-018-03705-y ↗
3. 10.1016/j.tibtech.2016.07.00610.1016/j.tibtech.2016.07.006 ↗
4. 10.1126/science.122956810.1126/science.1229568 ↗
5. 10.1016/j.tibtech.2013.09.00710.1016/j.tibtech.2013.09.007 ↗
6. 10.1007/s00432-014-1767-310.1007/s00432-014-1767-3 ↗
7. 10.1021/acs.bioconjchem.8b0073210.1021/acs.bioconjchem.8b00732 ↗
8. 10.1016/j.addr.2007.06.00810.1016/j.addr.2007.06.008 ↗
9. 10.2217/nnm-2018-032610.2217/nnm-2018-0326 ↗
10. 10.1016/j.jconrel.2010.11.00410.1016/j.jconrel.2010.11.004 ↗
11. 10.1039/c2nr31064c10.1039/c2nr31064c ↗
12. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
13. 10.1038/nbt.261410.1038/nbt.2614 ↗
14. 10.1023/A:102221900355110.1023/A:1022219003551 ↗
15. 10.1016/j.nantod.2014.04.01110.1016/j.nantod.2014.04.011 ↗
16. 10.1101/cshperspect.a01698010.1101/cshperspect.a016980 ↗
17. 10.1016/j.ijpharm.2021.12055610.1016/j.ijpharm.2021.120556 ↗
18. 10.1016/j.biochi.2019.02.01210.1016/j.biochi.2019.02.012 ↗
19. 10.1021/acs.accounts.9b0017710.1021/acs.accounts.9b00177 ↗
20. 10.1007/s00018-006-6456-110.1007/s00018-006-6456-1 ↗
21. 10.1007/s00109-006-0119-410.1007/s00109-006-0119-4 ↗
22. 10.1021/bc100060910.1021/bc1000609 ↗
23. 10.1039/D1NR05357D10.1039/D1NR05357D ↗
24. 10.1021/nn305663e10.1021/nn305663e ↗
25. 10.1021/nn403395410.1021/nn4033954 ↗
26. 10.1039/C8NR09431D10.1039/C8NR09431D ↗
27. 10.1016/j.jconrel.2020.04.01010.1016/j.jconrel.2020.04.010 ↗
28. 10.1186/s13045-020-00965-410.1186/s13045-020-00965-4 ↗
29. 10.1021/jm020033k10.1021/jm020033k ↗
30. 10.1158/1535-7163.MCT-15-086710.1158/1535-7163.MCT-15-0867 ↗
31. 10.1016/j.jconrel.2019.08.03310.1016/j.jconrel.2019.08.033 ↗
32. 10.1002/smll.20180509710.1002/smll.201805097 ↗
33. 10.1016/j.actbio.2009.04.02110.1016/j.actbio.2009.04.021 ↗
34. 10.1073/pnas.150012811210.1073/pnas.1500128112 ↗